Figure 1.
Survival outcomes after CD19 CAR T-cell therapy in patients with and without evidence of disease at the time of infusion. (A) EFS after CAR T-cell therapy. (B) OS after CAR T-cell therapy.
Survival outcomes after CD19 CAR T-cell therapy in patients with and without evidence of disease at the time of infusion. (A) EFS after CAR T-cell therapy. (B) OS after CAR T-cell therapy.
